S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study
- PMID: 29545905
- PMCID: PMC5818900
- DOI: 10.1155/2018/2358451
S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study
Abstract
Background: Electroconvulsive therapy (ECT) is one of the most effective treatment options for refractory depressed patients. To date, there are only a few predictors of response.
Aim: The aim was to identify predictive biomarkers of remission to ECT on a molecular level.
Methods: 11 patients suffering from a major depressive episode-according to the Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)-underwent 10 ECT sessions. Blood samples were taken, and the depression severity was assessed before, one hour and 24 hours after sessions 1, 4, 7, and 10 using the Montgomery Asberg Depression Rating Scale (MADRS). A MADRS total score < 12 was interpreted as remission.
Results: Patients remitting under ECT had significantly higher homocysteine (p < 0.001), S100B (p < 0.001), and procalcitonin (PCT) (p = 0.027) serum levels. On the contrary, serum levels of vitamin B12 (p < 0.001) and folic acid (p = 0.007) were significantly lower in remitters compared to those in nonremitters. Levels remained unchanged throughout the whole ECT course.
Conclusions: Our findings indicate that lower levels of vitamin B12 and folic acid associated with higher levels of homocysteine, S100B, and PCT point to a subgroup of depressed patients sensitive to ECT. Due to the limited sample size, further studies are required to replicate our findings.
Figures




Similar articles
-
S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy.Psychoneuroendocrinology. 2019 Dec;110:104414. doi: 10.1016/j.psyneuen.2019.104414. Epub 2019 Aug 24. Psychoneuroendocrinology. 2019. PMID: 31493698 Clinical Trial.
-
Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.J Clin Psychiatry. 2018 Mar/Apr;79(2):17m11597. doi: 10.4088/JCP.17m11597. J Clin Psychiatry. 2018. PMID: 29489077 Free PMC article.
-
Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes.Neuroimmunomodulation. 2008;15(3):145-52. doi: 10.1159/000151527. Epub 2008 Aug 21. Neuroimmunomodulation. 2008. PMID: 18716414 Clinical Trial.
-
Treatment of depression: time to consider folic acid and vitamin B12.J Psychopharmacol. 2005 Jan;19(1):59-65. doi: 10.1177/0269881105048899. J Psychopharmacol. 2005. PMID: 15671130 Review.
-
Serum homocysteine, folate, and vitamin B12 levels in patients with vitiligo and their potential roles as disease activity biomarkers: A systematic review and meta-analysis.J Am Acad Dermatol. 2019 Mar;80(3):646-654.e5. doi: 10.1016/j.jaad.2018.08.029. Epub 2018 Aug 28. J Am Acad Dermatol. 2019. PMID: 30165163
Cited by
-
Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders.J Pers Med. 2020 Sep 9;10(3):119. doi: 10.3390/jpm10030119. J Pers Med. 2020. PMID: 32916852 Free PMC article. Review.
-
Chronic Food Antigen-specific IgG-mediated Hypersensitivity Reaction as A Risk Factor for Adolescent Depressive Disorder.Genomics Proteomics Bioinformatics. 2019 Apr;17(2):183-189. doi: 10.1016/j.gpb.2019.05.002. Epub 2019 Jun 21. Genomics Proteomics Bioinformatics. 2019. PMID: 31233833 Free PMC article.
-
Effects of modifying the pulse width on cognitive side effects with electroconvulsive therapy for schizophrenia.Schizophr Res Cogn. 2025 May 24;41:100369. doi: 10.1016/j.scog.2025.100369. eCollection 2025 Sep. Schizophr Res Cogn. 2025. PMID: 40502546 Free PMC article.
-
Altered blood parameters in "major depression" patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study.Transl Psychiatry. 2024 Jun 25;14(1):264. doi: 10.1038/s41398-024-02942-8. Transl Psychiatry. 2024. PMID: 38918365 Free PMC article. Clinical Trial.
-
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.Int J Neuropsychopharmacol. 2022 Jun 21;25(6):468-478. doi: 10.1093/ijnp/pyac016. Int J Neuropsychopharmacol. 2022. PMID: 35176771 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous